Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 198 clinical trials
OMEGA, Local Ablative Therapy in Oligometastatic NSCLC (OMEGA)

tumors has been designed. Inclusion criteria include adequate performance status, primary tumor controlled or controllable staging with whole-body FDG PET scan and brain MRI, fit to receive at

brain metastases
metastasis
ct scan
stage iv non-small cell lung cancer
EGFR
  • 0 views
  • 24 Feb, 2022
  • 1 location
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

Positron Emission Tomography (PET) scan will allow doctors to monitor the progress of IO therapy.

primary cancer
  • 0 views
  • 10 May, 2022
  • 1 location
The PET- Retroperitoneal Sarcoma Study

response. Functional imaging by PET scan is used in other tumour types to identify early response to treatment. PET imaging may provide a more meaningful assessment of RPS response to systemic therapy

  • 0 views
  • 18 Apr, 2021
  • 1 location
Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

To evaluate the treatment outcome of unresectable soft tissue sarcoma using response based treatment

  • 0 views
  • 23 Feb, 2022
Understanding Factors That Influence Electronic Cigarette Nicotine Delivery Through PET Imaging of Beta-2 Nicotinic Acetylcholine Receptors

The goal of this proposal is to test the overall hypothesis that e-cigarettes (ECs) provide efficient nicotine delivery to the brain and arterial blood in non-EC-naïve smokers and e-cigarette users and that EC liquid characteristics modulate this effect. This study will test the hypothesis through complementary methods that include [ …

  • 83 views
  • 23 Mar, 2022
  • 1 location
Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT) (Ev-NIRT)

Parkinson's disease has only pharmacological (essentially dopaminergic) and surgical treatment (essentially high-frequency deep brain stimulation), that are symptomatically effective. none of them is curative, and has the ability to slow down the disease and to protect dopaminergic neurons from death by neurodegeneration. Experimental results, based on preclinical studies, suggest that …

  • 0 views
  • 25 May, 2022
  • 1 location
Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults (COGFRAIL)

The current study seeks to examine the prevalence of amyloid pathology, among patients referred to the Toulouse Geriatric Frailty Clinic presenting objective memory impairment. We also aim to fully characterize the clinical progression of frail cognitively impaired patients presenting AD (Alzheimer Disease) pathology vs those who also present a cognitive …

  • 0 views
  • 25 Feb, 2022
  • 1 location
Radium-223 in Biochemically Recurrent Prostate Cancer

Background Some men who have been treated for localized prostate cancer with surgery or radiation still show signs of the disease in their blood. This is called biochemically recurrent prostate cancer. Radium-223 is a small molecule. It uses radiation to kill cancer cells and improves survival in advanced prostate cancer. …

  • 0 views
  • 27 Jun, 2022
  • 1 location
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies

This is a pilot phase 2 single-arm study, of men with metastatic castration-resistant prostate cancer (mCRPC). Patients will be treated with any of the approved life-prolonging therapies: abiraterone 1000 mg daily plus prednisone 5 mg (or dexamethasone 0.5 mg) daily, enzalutamide 160 mg daily, or docetaxel 50 mg/m2 every two …

soft tissue disease
metastasis
luteinizing hormone
neutrophil count
docetaxel
  • 0 views
  • 21 Oct, 2021
  • 1 location
Medical Imaging of Cachexia

This is a pilot trial using 18F-FDG PET and DXA scans to determine whether these investigations are objective tools to assess cachexia.

malignant disease
medical imaging
sarcopenia
  • 0 views
  • 25 May, 2022
  • 1 location